Tag Archives: bosutinib

Health Policy Updates: December 23 2017

The individual mandate – viewed by many as an essential component of the ACA/Obamacare in order to maintain insurance market stability – was officially repealed this week with the passage of the GOP tax bill. Health Affairs has compiled a list of resources discussing the possible implications of mandate repeal.

According to health policy expert Timothy Jost:

“The CBO, in its most recent analysis of the individual mandate repeal proposal, projected that repeal would result in four million more uninsured by 2019, 13 million more by 2027. Repeal would increase premiums in the individual market by 10 percent or more in most years…But the repeal of the individual mandate penalty will not by any means bring an end to the ACA. The numbers who lose coverage will likely be much smaller than the CBO estimates.”

Continue reading Health Policy Updates: December 23 2017